NCT04184674

Brief Summary

Pulmonary distension induced by mechanical ventilation physiologically alters right ventricle pre and after-load, hence might lead to right ventricle failure. The hypothesis is that in Acute Respiratory Distress Syndrome, the occurence of a right ventricle failure under lung protective ventilation might : i) be correlated to the transpulmonary pressure level, ii) lead to global heart failure, iii) and extremely result in poor outcome and death. The primary objective is to test the impact of transpulmonary pressure on right ventricular function in Acute Respiratory Distress Syndrome in adults and children. Secondary objectives are : i) to compare thresholds of transpulmonary pressure associated with right ventricle failure between children and adults. ii) to assess if there is an association between transpulmonary pressure and morbidity and mortality. \- For pediatric patients, a specific monitoring with electrical impedance tomography (EIT) will allow:

  • To assess if the transpulmonary pressure is associated with the level of regional pulmonary overdistention (or collapse) on electrical impedance tomography.(EIT)
  • To assess if there is an association between the occurrence of right ventricular failure, and distribution of ventilation on EIT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 3, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

June 11, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2022

Completed
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

November 28, 2019

Last Update Submit

March 9, 2026

Conditions

Keywords

Acute Respiratory Distress SyndromeMechanical ventilationTranspulmonary pressureRight ventricle failure

Outcome Measures

Primary Outcomes (1)

  • Right ventricle failure

    Right ventricle failure is defined, by ultrasound, as a composite criteria associating : * end-diastolic right ventricle/left ventricle area ratio \> 0.6 and/or Acute Cor Pulmonale (assocation with a septal dyskinesia), * and/or a tricuspid annular plane systolic excursion \< 1,6 cm (adults), z-score \< -2 (children), * and/or a doppler-derived tricuspid lateral annular systolic velocity (S wave) \< 10 cm/s, * and/or a two-dimensional Fractional Area Change (defined as end-diastolic area - end-systolic area)/end-diastolic area x100) \< 35%, * and/or a peak right ventricle free wall 2D strain \< -30% (adults), z-score \< 2 (children).

    Three days

Secondary Outcomes (13)

  • Airways pressure

    Three days

  • Oesophageal pressure

    Three days

  • Transpulmonary pressure calculation

    Three days

  • Vaso-Active Inotrope Score (VIS)

    Three days

  • Duration of treatment with vasoactive or inotropic drugs

    3 months after hospitalization in Intensive Care Unit

  • +8 more secondary outcomes

Study Arms (1)

Acute Respiratory Distress Syndrome

OTHER

Children of more than one month of age and adults hospitalized in Intensive Care Unit for Acute Respiratory Distress Syndrome.

Other: PneumotachographOther: Esophageal catheterOther: Transthoracic and / or transesophageal cardiac ultrasoundOther: Electrical impedance tomography (EIT) for pediatric patients

Interventions

Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management : * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).

Acute Respiratory Distress Syndrome

Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).

Acute Respiratory Distress Syndrome

The right ventricle systolic function will be assessed thanks to a transthoracic cardiac ultrasound in children, and a transthoracic of a transesophageal cardiac ultrasound in adults : Measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management : * The first measurement will be performed 5 minutes after the initial ventilator settings. * Measurements will be repeated systematically at 24 hours, 48 hours and 72 hours of evolution. * An additional measure will be performed at each positive end-expiratory pressure modification (maximum 5 measures).

Acute Respiratory Distress Syndrome

For pediatric patients: measurements will be performed during the first three days of Acute Respiratory Distress Syndrome management.

Acute Respiratory Distress Syndrome

Eligibility Criteria

Age1 Month+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over one month
  • Patients with mild to severe ARDS (onset within 48 hours). ARDS definition will follow Berlin guidelines for adults, and Pediatric Acute Lung Injury Consensus Conference (PALICC) guidelines for children
  • Signed consent

You may not qualify if:

  • Neonates less than 28 days-old
  • Pregnancy or breastfeeding
  • Any contra-indication to esophageal manometry (less than one month esophagus surgery, bronchopleural or esotracheal fistula, latex allergy)
  • No social care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Ambroise Paré

Boulogne-Billancourt, 92100, France

Location

Hôpital Necker-Enfants Malades

Paris, 75015, France

Location

Related Publications (1)

  • Vedrenne-Cloquet M, Petit M, Khirani S, Charron C, Khraiche D, Panaioli E, Habib M, Renolleau S, Fauroux B, Vieillard-Baron A. Impact of the transpulmonary pressure on right ventricle impairment incidence during acute respiratory distress syndrome: a pilot study in adults and children. Intensive Care Med Exp. 2024 Sep 27;12(1):84. doi: 10.1186/s40635-024-00671-2.

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Meryl Vedrenne-Cloquet, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
  • Brigitte Fauroux, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2019

First Posted

December 3, 2019

Study Start

June 11, 2020

Primary Completion

June 11, 2022

Study Completion

June 11, 2022

Last Updated

March 11, 2026

Record last verified: 2026-03

Locations